ID1 and diabetes mellitus: At baseline, patients in the NHS cohort who eventually progressed to diabetes (progressors) had significantly lower median anti-Id levels compared to non-progressors (index of 0.06 vs. 0.08, respectively, p = 0.02) (Figure 1).